11Skin’s co-founders, Eva and Dr. Yannis Alexandrides, will retain majority ownership and continue to lead the company, along with CEO Vanessa Goddevrind.
With SKKY’s support, 111Skin aims to strengthen its direct-to-consumer business while expanding its customer base in North America and Asia.
CEO Vanessa Goddevrind said,
“The SKKY Partners team has tremendous experience working with distinctive, growth-oriented brands. They are passionate champions of our core values and share our drive for excellence.”
111Skin was founded in 2012 by plastic and reconstructive surgeon Dr. Yannis Alexandrides. The brand features clinically inspired formulations, highly effective active ingredients, and breakthrough technologies.
Leveraging Dr. Yannis’s experience treating patients in London’s 111 Harley Street Clinic, 111Skin’s products include a proprietary NAC Y2 ingredient complex.
This partnership aligns with SKKY’s ambition to support high-quality, enduring, and growing companies.
SKKY brings investment expertise with a deep understanding of the modern consumer, culture, social platforms, and an array of distribution channels to support the growth of the companies it invests in.
David Brisske, SKKY Partners Managing Director, said,
“Eva, Yannis, Vanessa, and the 111SKIN team have created and nurtured a coveted brand with world-class products and a loyal customer base, which fits perfectly with SKKY’s strategy. 111Skin has a strong foundation and significant ongoing potential, and we are honored to partner with the founders and leadership for the next phase of growth.”
Widely recognized among celebrities, A-listers, and high-profile makeup artists, 111Skin has over 25 awards received for its skincare innovations in 2024.
Read Next
Mergers & Acquisitions in the Beauty Industry in 2025
